Luo Li, member of the party group and deputy director of Chongqing Economic and Information Technology Commission, Sun Qinghua, deputy director of Pharmaceutical Division, Wang Yong, standing committee member of Dadukou District, minister of the organization department of the district party committee, Liu Zhen, deputy mayor of the district government, Yuan Li, director of the district Economic and Information Technology Commission, Chen Bei, director of the office of the district Federation of Industry and Commerce, Song Haibo, vice president of the National Health Industry Enterprise Management Association and president of the medical testing industry branch, president of Shanghai Institute of Experimental Medicine, director of the National Health Industry Wang Hualiang, President of Shanghai Institute of Experimental Medicine and Director of National Health Industry Management Association Experimental Medicine Branch, as well as District Government Office, District People's Congress, District Economic and Information Commission, District Federation of Industry and Commerce, Jianqiao Company, Big Health Biomedical Industry Office Company and other relevant officials attended the signing ceremony.

Ji Quan, the founder of Zybio, mentioned in the ceremony: Among the blood and body fluid tests, blood coagulation tests have an indispensable and important position and play a significant role in experimental diagnosis.

The signing of this acquisition cooperation is undoubtedly an important development opportunity for both Zybio and Shenzhen Thistory Bio-Medical Company. This acquisition provides a new impetus and important support for Zybio to enter the field of coagulation testing in the future and give a great impetus to the diversified system development strategy of Zybio in the IVD industry, which will further enhance the company's competitiveness and expand its development space in the biomedical field.